

CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: SEMAGLUTIDE
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 7 DAYS
DOSAGE: 0.25-0.5 MG WEEKLY, TITRATE AS NEEDED
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
Stealth Labs Semaglutide 5 mg delivers a pharmaceutical-grade GLP-1 receptor agonist used in advanced metabolic and weight management research. Each 2 mL vial contains 5 mg of Semaglutide, produced under strict research-grade standards for consistent quality and purity.
Semaglutide is a GLP-1 receptor agonist studied for its effects on promoting weight loss, improving blood sugar regulation, and supporting cardiovascular health. It mimics the effects of natural incretin hormones, enhancing insulin secretion while reducing appetite [Clinical Study].
Research protocols typically involve subcutaneous injections starting at lower doses (e.g., 0.25-0.5 mg weekly) with gradual titration based on research goals. Full dosing cycles often extend over several weeks to months. Professional supervision is highly recommended during research applications.
Enhance your weight management research stack by combining Semaglutide with Cagrilintide 10 mg from Stealth Labs USA. Explore more premium peptides in the Stealth Labs Peptides category.
Semaglutide is studied for weight management, glycemic control, appetite suppression, and enhancing metabolic health by mimicking natural GLP-1 hormone activity.
Research dosing typically starts at 0.25-0.5 mg weekly, with gradual increases based on tolerance and study design. Subcutaneous injections are the preferred method.
Semaglutide has demonstrated a strong safety profile in research studies. Mild gastrointestinal effects (nausea, bloating) are possible during initial titration phases.
Authentic Semaglutide 5 mg is available from our Stealth Labs USA Peptides catalog, featuring premium research peptides.
Please log in to write SEMAGLUTIDE review.
CLASSIFICATION: REGENERATIVE PEPTIDE
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 4–6 HOURS
DOSAGE: 200–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: TIRZEPATIDE
FORM: LYOPHILIZED POWDER – 2 ML VIAL (20 MG/VIAL)
ACTIVE HALF-LIFE: ~5 DAYS
DOSAGE: 2.5 - 5 MG/WEEK (RESEARCH USE ONLY)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS USA
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: REGENERATIVE PEPTIDE
ACTIVE SUBSTANCE: THYMOSIN BETA 4
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 2–3 HOURS
DOSAGE: 2–5 MG TWICE WEEKLY (LOADING), THEN ONCE WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (R-HGH)
ACTIVE SUBSTANCE: SOMATROPIN
FORM: 1 KIT (10 VIALS x 36 IU/VIAL)
ACTIVE HALF-LIFE: ~ 3–4 HOURS
DOSAGE: 2-6 IU DAILY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): POSSIBLE AT HIGH DOSES
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: AMYLIN RECEPTOR AGONIST
ACTIVE SUBSTANCE: CAGRILINTIDE
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 7 DAYS
DOSAGE: 0.3\u20131.8 MG WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!